dysfunct
bloodbrain
barrier
bbb
primari
characterist
experiment
autoimmun
encephalomyel
eae
experiment
model
multipl
sclerosi
ms
matrin
mat
quinolizidin
alkaloid
deriv
herb
radix
sophora
flave
recent
found
suppress
clinic
eae
cn
inflamm
howev
whether
effect
mat
protect
integr
function
bbb
known
present
studi
show
mat
treatment
therapeut
effect
compar
dexamethason
dex
eae
rat
reduc
evan
blue
extravas
increas
express
collagen
iv
major
compon
basement
membran
structur
tight
junction
tj
adaptor
protein
zonula
furthermor
mat
treatment
attenu
express
matrix
increas
express
tissu
inhibitor
find
demonstr
mat
reduc
bbb
leakag
strengthen
basement
membran
inhibit
activ
upregul
inhibitor
taken
togeth
result
identifi
novel
mechan
underli
effect
mat
natur
compound
could
novel
therapi
ms
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
cellmedi
inflammatori
diseas
character
lymphocyt
infiltr
demyelin
axon
injuri
although
ms
patholog
fulli
understood
bloodbrain
barrier
bbb
dysfunct
play
essenti
role
pathogenesi
diseas
ms
eae
proinflammatori
cell
toxic
molecul
migrat
brain
via
damag
bbb
result
cerebr
edema
demyelin
neural
cell
death
bbb
compos
basement
membran
interendotheli
tight
junction
tj
perivascular
astrocyt
basement
membran
compos
two
distinct
type
name
endotheli
basement
membran
parenchym
basement
membran
tight
assembl
special
extracellular
matrix
molecul
membran
togeth
endotheli
cell
monolay
form
structur
barrier
select
filter
blood
element
collagen
iv
compris
total
protein
basement
membran
play
decis
role
maintain
structur
integr
vessel
wall
collagen
iv
major
compon
cerebr
microvascular
basal
lamina
wide
use
marker
determin
extent
destruct
basement
membran
tj
compos
larg
multiprotein
complex
seal
gap
biolog
barrier
alter
distribut
loss
tj
frequent
seen
ischem
cerebr
microvessel
result
diminish
bbb
integr
zonula
primari
cytoplasmat
protein
associ
tj
link
ctermin
end
occludin
claudin
underli
actin
cytoskeleton
decreas
express
result
increas
bbb
permeabl
addit
diseas
sever
acut
phase
eae
directli
associ
extent
bbb
permeabl
shown
bbb
disrupt
accompani
excess
express
matrix
metalloproteinas
mmp
mmp
includ
belong
class
zincbound
proteas
whose
function
includ
induct
inflamm
cleavag
myelin
protein
activ
degrad
diseasemodifi
cytokin
direct
damag
cn
cell
abnorm
increas
endotheli
cell
may
collect
impair
endotheli
barrier
function
degrad
vascular
basement
membran
tj
furthermor
upregul
cn
rat
model
eae
tissu
inhibitor
metalloproteinas
timp
endogen
inhibitor
mmp
control
activ
high
affin
noncoval
bind
mmp
catalyt
domain
wherea
bound
shown
defici
enhanc
diseas
sever
eae
normal
physiolog
condit
constant
balanc
mmp
timp
activ
essenti
maintain
physiolog
function
organ
contrast
imbal
mmptimp
ratio
found
variou
patholog
condit
human
cancer
rheumatoid
arthriti
vascular
diseas
exampl
serum
ratio
relapsingremit
ms
patient
correl
develop
diseas
imbal
caus
radiat
play
role
pathogenesi
brain
injuri
current
treatment
ms
limit
immunomodulatori
immunosuppress
therapi
alway
success
often
sever
side
effect
henc
search
effect
toler
compound
great
import
matrin
mat
natur
alkaloid
compon
extract
herb
radix
sophora
flave
mw
c
h
n
figur
report
mat
suppress
immun
activ
cell
b
cell
macrophag
matrin
long
use
treatment
viral
hepat
cardiac
arrhythmia
skin
inflamm
without
known
side
effect
mat
suppress
develop
eae
mechan
neuroprotect
elucid
purpos
studi
determin
whether
mat
treatment
inhibit
bbb
disrupt
reduc
bbb
leakag
strengthen
basement
membran
enhanc
tj
regul
balanc
mmp
timp
diseas
progress
eae
anim
femal
weekold
wistar
rat
purchas
shanghai
xipuerbikai
experiment
anim
compani
china
hous
asept
laboratori
experiment
anim
center
henan
china
effort
made
minim
number
anim
use
ensur
minim
suffer
treatment
eae
induc
describ
previous
minor
modif
spinal
cord
homogen
guinea
pig
experiment
anim
center
hebei
weigh
g
emulsifi
volum
complet
freund
adjuv
cfa
sigma
usa
contain
mgml
bacillu
vaccin
shanghai
institut
biolog
product
china
rat
receiv
subcutan
inject
ml
emuls
divid
among
site
drain
nape
back
procedur
approv
bioethic
committe
zhengzhou
univers
immun
rat
randomli
divid
four
group
group
differ
treatment
briefli
mat
jiangsu
chia
tai
tianq
pharmaceut
co
jiangsu
china
dissolv
normal
salin
inject
intraperiton
ip
daili
two
dose
low
mgkg
matl
high
mgkg
math
dosag
calcul
mlkg
day
day
immun
pi
dexamethason
dex
henan
hongrun
pharmaceut
co
henan
china
posit
control
drug
dissolv
normal
salin
mlkg
inject
ip
daili
day
day
pi
mgkg
immun
rat
receiv
amount
normal
salin
ip
serv
vehicl
control
nonimmun
naiv
rat
receiv
amount
normal
salin
ip
serv
naiv
group
rat
monitor
weigh
daili
two
independ
observ
evalu
clinic
score
eae
immun
neurolog
sign
assess
follow
clinic
score
loss
tail
tone
hind
limb
weak
hind
limb
paralysi
forelimb
paralysi
moribund
death
day
pi
two
independ
observ
randomli
select
rat
group
anim
sacrif
sera
spinal
cord
collect
extens
perfus
lumbar
enlarg
spinal
cord
embed
paraffin
embed
thick
section
prepar
stain
hematoxylineosin
inflammatori
infiltr
chromotrop
green
demyelin
histopatholog
examin
perform
score
blind
fashion
follow
inflamm
inflammatori
cell
scatter
inflammatori
cell
organ
inflammatori
infiltr
around
blood
vessel
extens
perivascular
cuf
extens
adjac
parenchyma
parenchyma
demyelin
none
rare
foci
area
demyelin
larg
confluent
area
demyelin
bbb
leakag
assess
use
evan
blue
eb
dye
previous
describ
day
pi
rat
remain
group
anesthet
eb
dye
mlkg
sigma
st
loui
mo
usa
inject
slowli
tail
vein
allow
circul
minut
rat
sacrif
brain
remov
immedi
weigh
eb
dye
extract
ml
pb
ml
trichloroacet
acid
ad
mixtur
vortex
centrifug
min
rpm
amount
eb
dye
supernat
determin
nm
spectrophotometri
quantifi
gg
brain
tissu
cervic
spinal
cord
harvest
day
pi
prepar
analysi
collagen
iv
mrna
use
realtim
polymeras
chain
reaction
pcr
total
cellular
rna
tissu
isol
use
trizol
reagent
beij
transgen
biotech
co
beij
china
follow
standard
protocol
cdna
synthesi
perform
revers
transcript
use
promega
revers
transcript
kit
cdna
copi
number
gene
determin
use
standard
curv
correspond
pcr
product
primer
collagen
iv
forward
revers
produc
bp
pcr
product
primer
forward
revers
produc
bp
pcr
product
gene
express
normal
express
endogen
housekeep
gene
actin
actin
primer
forward
revers
produc
bp
pcr
product
determin
rel
quantif
target
gene
express
use
gel
imag
analysi
system
dalian
jingmai
biotech
co
liaon
china
serum
collect
day
pi
assay
concentr
elisa
follow
manufactur
instruct
r
system
usa
sampl
quantifi
comparison
standard
curv
ngml
paraffinembed
tissu
spinal
cord
group
cut
thick
section
immunohistochemistri
perform
slice
use
antirat
antibodi
beij
transgen
biotech
co
beij
china
section
rins
incub
nonbiotinyl
goat
antirabbit
igg
secondari
antibodi
chromophor
product
develop
use
simpl
stain
dab
solut
beij
transgen
biotech
co
beij
china
integr
optic
densiti
iod
posit
cell
restrict
area
determin
repres
express
use
biosen
digit
imag
system
statist
analysi
data
present
mean
sd
statist
analysi
perform
spss
spss
chicago
usa
multipl
comparison
perform
use
kruskalw
test
anova
follow
lsdt
test
appropri
valu
less
consid
signific
vehicletr
group
clinic
declin
typic
start
day
pi
eae
onset
mattreat
rat
occur
day
pi
low
dose
pi
high
dose
figur
b
compar
vehicletr
group
mattreat
group
exhibit
significantli
lower
mean
maximum
clinic
score
figur
c
bodi
weight
loss
tabl
treatment
dex
also
delay
diseas
progress
reduc
clinic
score
compar
vehicletr
group
signific
differ
anim
treat
dex
two
differ
dose
mat
assess
eae
neuropatholog
lumbar
enlarg
spinal
cord
sampl
examin
use
h
e
myelin
stain
figur
perivascular
cuf
mononuclear
cell
infiltr
cn
parenchyma
observ
spinal
cord
rat
vehicletr
group
figur
extent
cellular
infiltr
significantli
decreas
mattreat
group
treatment
dex
show
stronger
inhibit
cellular
infiltr
mattreat
group
cellular
infiltr
observ
naiv
group
moreov
shown
figur
larg
area
demyelin
observ
vehicletr
group
matand
dextreat
group
exhibit
area
demyelin
signific
differ
demyelin
observ
math
dex
group
destruct
bbb
one
import
featur
ms
eae
quantifi
extravas
eb
dye
brain
indic
bbb
permeabl
eb
extravas
brain
vehicletr
eae
rat
significantli
higher
naiv
brain
figur
content
eb
significantli
decreas
matand
dextreat
group
compar
vehicletr
group
profound
decreas
eb
content
observ
rat
treat
math
dex
matl
signific
differ
observ
treat
high
dose
mat
dex
determin
basement
membran
disrupt
evalu
mrna
express
collagen
iv
major
compon
cerebr
microvascular
basement
membran
use
rtpcr
analysi
shown
figur
brightest
band
exhibit
naiv
group
faintest
band
vehicletr
group
consist
quantit
analysi
figur
c
dosedepend
increas
collagen
iv
express
observ
mattreat
group
matltreat
group
show
lower
collagen
iv
express
dex
group
signific
differ
math
dex
group
also
assess
mrna
express
determin
tj
disrupt
similar
pattern
mrna
express
observ
collagen
iv
figur
b
c
serum
concentr
measur
elisa
amount
dramat
increas
vehicletr
group
compar
naiv
group
figur
mat
treatment
larg
reduc
content
compar
vehicletr
group
effect
dose
depend
furthermor
significantli
lower
amount
observ
dextreat
group
mattreat
group
also
measur
serum
concentr
differ
group
figur
show
signific
decreas
concentr
vehicletr
group
compar
naiv
group
serum
level
mattreat
group
significantli
higher
vehicletr
group
low
dose
mat
induc
lower
serum
level
dex
high
dose
mat
increas
serum
level
greater
extent
dex
determin
balanc
cn
express
spinal
cord
measur
immunohistochemistri
shown
figur
express
significantli
increas
vehicletr
group
naiv
group
differ
express
vehicletr
two
mattreat
group
signific
furthermor
effect
dex
decreas
content
stronger
lowdos
mat
signific
differ
compar
math
group
measur
content
use
method
shown
figur
express
vehicletr
group
significantli
lower
naiv
group
mattreat
group
significantli
lower
amount
obtain
matl
group
math
group
matltreat
group
show
lower
express
dextreat
group
signific
differ
math
dex
group
although
administr
mat
reduc
cn
inflammatori
infiltr
demyelin
effect
natur
compound
bbb
yet
studi
present
studi
provid
evid
therapeut
effect
mat
least
partial
strengthen
bbb
integr
protect
basement
membran
well
tj
protein
abil
regul
balanc
mmp
timp
peripheri
cn
bbb
destruct
implic
mani
cn
diseas
ms
stroke
ms
patient
eae
model
breakdown
bbb
earli
critic
event
associ
influx
inflammatori
cell
ultim
poor
outcom
thu
quantifi
extravas
eb
dye
brain
indic
bbb
permeabl
inde
studi
show
eb
leakag
markedli
increas
eae
model
associ
decreas
collagen
iv
express
vehicletr
rat
compar
naiv
rat
mat
treatment
larg
figur
bbb
integr
evan
blue
iv
inject
day
pi
brain
harvest
min
determin
evan
blue
extravas
result
express
mean
sd
group
compar
naiv
group
compar
vehicl
group
compar
dex
group
comparison
matl
math
group
significantli
decreas
eb
content
brain
compar
vehicl
group
togeth
result
demonstr
bbb
integr
compromis
develop
eae
mat
treatment
protect
bbb
bbb
integr
depend
adequ
structur
support
basement
membran
collagen
iv
compris
total
protein
basement
membran
addit
collagen
iv
critic
cell
signal
interact
variou
receptor
adhes
molecul
express
therefor
marker
barrier
damag
impair
studi
lee
et
al
clearli
show
degrad
collagen
iv
role
pathogenesi
bbb
destruct
brain
injuri
date
known
whether
decreas
collagen
iv
contribut
bbb
damag
caus
eae
shown
present
studi
express
collagen
iv
mrna
significantli
decreas
vehicletr
group
compar
naiv
group
dosedepend
increas
collagen
iv
mrna
express
observ
mattreat
group
result
indic
collagen
iv
degrad
play
import
role
bbb
disrupt
mat
treatment
effect
preserv
content
collagen
iv
bbb
tj
compos
larg
multiprotein
complex
mediat
tight
intercellular
contact
among
adjac
cell
play
critic
role
maintain
bbb
function
improv
barrier
function
endotheli
level
previou
public
report
vari
degre
tj
patholog
eae
bennett
et
al
found
reloc
multidomain
polypeptid
requir
assembl
tj
preced
diseas
onset
correl
cn
infiltr
eae
similar
observ
studi
found
decreas
mrna
express
vehicletr
group
compar
naiv
group
mrna
level
significantli
improv
mat
treatment
dosedepend
manner
result
consist
preserv
collagen
iv
level
indic
protect
bbb
basement
membran
order
studi
mechan
bbb
protect
induc
mat
treatment
evalu
activ
balanc
mmp
timp
mmp
group
zinccontain
endopeptidas
cleav
compon
basement
membran
includ
fibronectin
laminin
proteoglycan
collagen
iv
found
focal
activ
close
associ
infiltr
cell
penetr
parenchym
basement
membran
upregul
result
degrad
tj
focal
ischemiareperfus
revers
mmp
inhibit
addit
select
upregul
ms
diseas
activ
describ
similarli
signific
increas
express
central
canal
cervic
spinal
cord
sign
inflamm
acut
eae
furthermor
among
mmp
famili
togeth
member
collagenas
iv
famili
implic
degrad
constitu
basement
membran
target
mmp
chemokin
consid
import
therapeut
approach
alon
combin
current
medic
enhanc
effect
neurolog
disord
ms
present
studi
signific
upregul
serum
observ
vehicletr
group
compar
naiv
group
mat
treatment
reduc
level
loss
collagen
iv
reduc
block
eae
studi
suggest
overexpress
eae
could
caus
agent
reduc
intens
collagen
iv
mat
treatment
inhibit
level
preserv
level
collagen
iv
thu
benefici
bbb
integr
activ
form
mmp
inhibit
famili
specif
inhibitor
tissu
inhibitor
metalloproteinas
timp
preferenti
inhibit
respect
found
normal
homeostasi
cn
requir
balanc
mmp
timp
imbal
molecul
often
associ
cn
patholog
exampl
radiationinduc
brain
injuri
associ
increas
ratio
signific
increas
ratio
also
correl
ms
activ
studi
imbal
observ
vehicletr
eae
group
upregul
downregul
also
case
balanc
could
specul
overexpress
eae
counterbalanc
matmedi
increas
express
thu
constitut
steadi
balanc
mmp
timp
attribut
improv
bbb
function
investig
therapeut
effect
mat
eae
compar
mat
dex
glucocorticoid
chosen
posit
control
drug
strong
abil
suppress
inflamm
mat
low
dose
show
weaker
effect
dex
compar
effect
observ
dex
math
group
stronger
effect
mat
improv
content
serum
believ
mat
would
prove
superior
dex
whose
longterm
use
carri
risk
sera
harvest
treat
nontreat
eae
rat
sera
naiv
rat
serv
control
product
determin
elisa
result
express
mean
sd
group
compar
naiv
group
compar
vehicl
group
compar
dex
group
comparison
matl
math
group
side
effect
common
system
glucocorticoid
occur
rel
prolong
period
side
effect
includ
hyperglycemia
hypertens
neg
calcium
balanc
osteoporosi
weight
gain
even
immunodefici
extens
use
dex
treatment
sever
acut
respiratori
syndrom
sar
often
result
hypocortisol
osteonecrosi
femor
head
caus
patient
lose
abil
work
contrast
patient
hepat
b
use
mat
long
time
show
signific
therapeut
effect
good
toler
minor
side
effect
infrequ
transient
dizzi
nausea
whether
longterm
use
mat
would
safer
fewer
side
effect
dex
need
investig
summari
studi
demonstr
improv
bbb
integr
one
mechan
mat
action
eae
therapi
effect
least
partial
inhibit
activ
protect
basement
membran
tight
junction
protein
thu
improv
bbb
integr
result
inflammatori
infiltr
cn
larg
reduc
therebi
protect
cn
tissu
proinflammatori
cellmediatorinduc
damag
process
immun
cell
extravas
partial
endotheli
cellmedi
process
whether
mat
reduc
pathway
immun
cell
infiltr
yet
known
nevertheless
result
present
studi
togeth
suppress
effect
mat
cell
safeti
suggest
mat
could
qualifi
effect
altern
medic
ms
therapi
studi
test
possibl
warrant
